The Gamble Behind a Takeover of Kenvue, Maker of Tylenol

Potentially huge legal issues are hovering over Kenvue. But Kimberly-Clark, which agreed to buy it for $40 billion, appears to think they’re manageable.

Več na: https://www.nytimes.com/2025/11/04/business/dealbook/kimberly-clark-kenvue-bid.html

nazaj